Côte d'Ivoire vs Sierra Leone: Prevalence rate of diabetes in adults
Côte d'Ivoire
6.9
in 2014
Sierra Leone
6.9
in 2014
Côte d'Ivoire rank
142nd
Sierra Leone rank
142nd
Prevalence rate of diabetes in adults over time
- Côte d'Ivoire
- Sierra Leone
How they compare
Côte d'Ivoire currently reports 6.9 against 6.9 in Sierra Leone, a difference of 0.
The two have swapped places 2 times across 35 shared years of data; in 1980 it was Sierra Leone ahead.
Côte d'Ivoire ranks 142nd and Sierra Leone ranks 142nd of 190 countries.
Across the 4 decades both report, Côte d'Ivoire averaged higher in 3 and Sierra Leone in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.63 | 3.68 | 0.05 | Sierra Leone |
| 1990s | 4.68 | 4.55 | 0.13 | Côte d'Ivoire |
| 2000s | 5.75 | 5.6 | 0.15 | Côte d'Ivoire |
| 2010s | 6.62 | 6.56 | 0.06 | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Côte d'Ivoire or Sierra Leone?
- Côte d'Ivoire, at 6.9 against 6.9 in Sierra Leone as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Côte d'Ivoire and Sierra Leone?
- 0, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Sierra Leone?
- 35 years are reported by both, from 1980 to 2014.
- How do Côte d'Ivoire and Sierra Leone rank globally for prevalence rate of diabetes in adults?
- Côte d'Ivoire ranks 142nd and Sierra Leone ranks 142nd of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.